 |
cabozantinib |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-02 00:00:00 |
| Sponsor | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 |
| |
cabozantinib |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-03-02 00:00:00 |
| Sponsor | Exelixis, Inc.;210 East Grand Avenue;South San Francisco, California, 94083 |